Sensitive & Specific: The Testing Newsletter: Who It's For and Who Sponsors It

Covers: Industry news and scientific insights on diagnostic testing, biomarkers, medical wearables, genomic screenings, and regulatory developments.
For: Diagnostics industry professionals, healthcare executives, clinical researchers, and medical device developers.
Best for: Life sciences professionals and healthcare technology leaders tracking developments in diagnostic testing and screening tools.
Skip if: Consumers seeking personal wellness advice or general healthcare tips.

Start with

Feature Focus: Wearables: the obstacles and opportunities: Explores the technical and design challenges involved in developing wearable medical diagnostic devices.
FDA review panel greenlights first MCED: Reports on regulatory approvals for multi-cancer early detection and AI diagnostic tools.
Why genetic tests for adults should include inherited cancer: Examines genomic testing advancements and rapid tumor classification programs in clinical settings.

Summarised by AI from 12 recent issues. Audience size is not included. Prices are not included. Report a mistake.